PRURITUS THERAPEUTICS MARKET ANALYSIS

Pruritus Therapeutics Market, by Drug Class (Corticosteroids, Antihistamines, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, and Others), by Indication (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Psoriasis, and Others), by Route of Administration (Oral, Parenteral, and Topical), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI4492
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Pruritus Therapeutics Market – Competitive landscape

Key players operating in the global pruritus therapeutics market include Pfizer Inc., Sanofi S.A., Amgen Inc., Almirall S.A , NJ Novartis Pharmaceuticals Corporation, MC2 Therapeutics A/S, EPI Health LLC, Allergan Plc., Astellas Pharma US, Inc., Mylan N.V., Johnson & Johnson, Vifor Pharma group, Cara Therapeutics Inc., and Aventis Pharma Ltd.